China Mengniu Dairy Company (CIADY) Fair Value & Analysis
Consumer Defensive · US · Market cap $7.7B
Analysis
China Mengniu Dairy Company (CIADY) currently trades at $20.47, while our model-based Fair Value estimate is $12.01 — implying the stock looks roughly 41.3% overvalued today. We read business quality at 85/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
China Mengniu Dairy Company Limited, an investment holding company, manufactures and distributes dairy products under the MENGNIU brand in the People's Republic of China, the Chinese Mainland and internationally. It operates in five segments: Liquid Milk Business, Ice Cream Business, Milk Formula Business, Cheese Business, and Others. The Liquid Milk Business segment offers ultra-high temperature milk, milk beverages, yogurt, and fresh milk. The Ice Cream Business segment manufactures and distributes dairy-based ice cream. The Milk Formula Business segment is involved in the manufacture and distribution of milk powder. The Cheese Business segment engages in the manufacture and distribution of cheese. The Other segment is involved in manufacturing raw materials for daily products; and trading business. It also produces and sells organic food and formula products for babies and toddlers; sells raw materials; and provides commercial factoring and financing guarantee services. China Men…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.